Lund, Sweden

Kristina Stenvall


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Kristina Stenvall: Pioneering Treatments for Airway Diseases

Introduction: Kristina Stenvall is a prominent inventor based in Lund, Sweden, recognized for her significant contributions to the field of pharmaceutical innovations. With a total of three patents to her name, she has focused her research on developing treatments for obstructive airway diseases, demonstrating her commitment to improving patient outcomes.

Latest Patents: Among her most notable patents is a groundbreaking invention involving hydantoin derivatives tailored for the treatment of obstructive airway diseases. This invention provides compounds of formula (I), where R and R' are defined as per the specification. The patent details processes for their preparation, pharmaceutical compositions that utilize these compounds, and the therapeutic uses of the compositions. The dual focus on formulation and application underscores the potential impact of her work in clinical settings.

Career Highlights: Kristina Stenvall's career is marked by her affiliation with AstraZeneca AB, a global leader in pharmaceutical development. Her role at AstranZeneca has allowed her to collaborate on advanced research initiatives, pushing the boundaries of medical science. Her innovative approach has positioned her as a leading figure in her field.

Collaborations: Kristina has had the opportunity to work alongside esteemed colleagues such as Balint Gabos and Lena Elisabeth Ripa. These collaborations reflect a spirit of teamwork and shared goals in the pursuit of scientific advancement, highlighting the importance of diverse expertise in the development of novel therapies.

Conclusion: With her innovative contributions and dedication to improving healthcare, Kristina Stenvall stands out as an influential inventor in the pharmaceutical sector. Her work on hydantoin derivatives not only showcases her ingenuity but also holds promise for the future of treatments for obstructive airway diseases. As she continues her journey in research and development, Kristina's impact on medicine is likely to grow, benefiting many around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…